Impact of Demodex Blepharitis on Patients and Healthcare System: Results from the Atlas Continuation Study

Show Description +

Blake Simmons, OD reviews highlights data from the Atlas Continuation Study that was presented at ARVO 2022, highlighting discussing the ongoing negative impact of Demodex blepharitis (DB) on patients

Posted: 5/02/2022

Up Next


Prevalence and Diagnosis of Demodex Blepharitis

Prevalence of Demodex Blepharitis

Sumitra S. Khandelwal, MD; Eric D. Rosenberg, DO; Neda Shamie, MD; Christopher E. Starr, MD; Nandini Venkateswaran, MD

Diagnosing Demodex Blepharitis

Sumitra S. Khandelwal, MD; Eric D. Rosenberg, DO; Neda Shamie, MD; Christopher E. Starr, MD; Nandini Venkateswaran, MD

Up Close with Demodex Blepharitis

Pathology of Demodex Blepharitis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Prevalence and Characterization

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Risk Factors and Comorbidities

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Diagnosis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Clinical Impact of Demodex Blepharitis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Demodex Blepharitis Co-Management

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Elevating Demodex Blepharitis As Part Of Eyelid Health

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Demodex Blepharitis Prevalence, Impact, and Diagnosis

Impact of Demodex Blepharitis on Patients and Healthcare System: Results from the Atlas Continuation Study

Blake Simmons, OD reviews highlights data from the Atlas Continuation Study that was presented at ARVO 2022, highlighting discussing the ongoing negative impact of Demodex blepharitis (DB) on patients

Posted: 5/02/2022

About Look at the Lids

While ~58% of eye care patients may have Demodex blepharitis (DB), it is often missed or misdiagnosed.1 Discover how to spot DB in your practice.

Visit us online: lookatthelids.com

Contact Us

Follow Look at the Lids